FDA Accepts BLA for Leqembi Autoinjector
If approved, subcutaneous autoinjector Leqembi will be the only Alzheimer's medication that can be administered at home. The FDA has set a goal date of Aug. 31, 2025.
Read More
Menopause Challenges Across Rural, Suburban and Urban Communities
Study authors Susan D. Reed, MD, MPH, MS, and Erin Dwyer, MPH, both at the University of Washington School of Medicine, attribute some of these different challenges to underlying health disparities.
Digital Lifeline | Predictions for 2025
A prediction of 2025 by Doug Mirsky, Ph.D., vice president of healthcare delivery at Digital Medicine Society.
Show us Your Prices | Predictions for 2025
A prediction for this year by Shawn Gremminger, president and CEO of National Alliance of Healthcare Purchaser Coalitions.
Out-of-Pocket Limits Increase Utilization | Predictions for 2025
Jerilyn Arneson, Pharm. D, co-founder and officer of the National Association of Medication Access & Patient Advocacy, gives her 2025 prediction.
Alan Silver First President at Ambetter Health Solutions Division
Centene Corporation’s Ambetter Health Solutions names Alan Silver as the first president of Individual Coverage Health Reimbursement Arrangements.
From Sidelines Into the Game | Predictions for 2025
A forecast for 2025 by Guy D’Andrea, MBA, executive director of Catalyst for Payment Reform.
Cancer Drugs Move from IV to SC | Predictions for 2025
A prediction for 2025 by Marci Chodroff, M.D., vice president of Medical Affairs at Prime Therapeutics and Managed Healthcare Executive editorial advisory board member.
Smart Money Bets on Value | Predictions for 2025
Kimberly Westrich, M.A., chief strategy officer of National Pharmaceutical Council, shares her prediction for 2025.
MHE Week in Review – 2025 Healthcare Predictions
Here’s what you missed this week on Managed Healthcare Executive.
AI Davids and Goliaths | Predictions for 2025
A forecast for this year by Dan Parsons, chief experience officer of Thoughtful AI.
RSV Vaccine Highly Effective in Preventing Severe Illness in Older Adults
U.S. approved the RSVpreF vaccine for adults 60 years and older in 2023, recommending it only based on individual’s decisions with their doctors.
Dysfunction at the FDA, NIH, Elsewhere | Predictions for 2025
Predictions for this year from Perry Cohen, Pharm.D., CEO of the TPG Family of Companies and Managed Healthcare Executive editorial advisory board member.
Pressure on Patient Assistance Programs | Predictions for 2025
Predictions for 2025 by Tracy Baroni Allmon, J.D., vice president of Market Access and Policy at Magnolia Market Access.
Lois Quam First Woman CEO of Blue Shield of California
Blue Shield of California new CEO Lois Quam said she will focus on the challenges that members face with accessing healthcare.
Cigna Group Foundation Grants $9 Million for Veteran Housing, Mental Stability
Over 20 nonprofit veteran advocacy groups will receive $9 million over the next three years to address homelessness and mental health concerns in veterans.
AI Hype and Engagement Fatigue | Predictions for 2025
A forecast for this year by Luis E. Taveras, Ph.D., senior vice president and chief information officer of Lehigh Valley Health Network.
Bringing in the Specialists | Predictions for 2025
A prediction for 2025 by Michael Meucci, president and CEO of Arcadia.
Power to the Patients | Predictions for 2025
A prediction for this year from Jason Spangler, M.D., M.P.H., CEO, Center for Innovation & Value Research.
Rural Women Experience Worse Menopausal Symptoms and Limited Resources, Study Finds
A new, first-of-its-kind study found that these symptoms occur particularly during the late menopause transition and post-menopause.
WHO to Develop Lenacapavir and HIV Testing Guidelines
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice yearly investigational pre-exposure prophylaxis (PrEP) injection.
Women’s Health Goes Beyond Reproduction, NIH Review Explains
Modern research shows women’s health issues go beyond reproductive health and highlight women’s elevated risk for autoimmune and cardiovascular disease – among other conditions.
MHE Week in Review – Regenerative Medicine for Vitiligo, Pain Patch Potential
Regenerative Medicine Offers Positive Results for Treating Vitiligo
Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.
Tafasitamab Shows Promising Results in Follicular Lymphoma Phase 3 Trial
Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.
Top 5 Conference Coverage Items of 2024
The year's top conference coverage item shares the effects of "Ozempic Bod" and "Ozempic Face," as presented at the annual American Academy of Ophthalmology meeting in Chicago.
Can Pain Be Patched Up?
A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the results might be described as, well, patchy.
Top 5 Biologics Articles of 2024
Check out this list of the top five biologics articles posted on Managed Healthcare Executive this year!
Top 5 Podcast Episodes of 2024
2024's top podcast episodes includes a conversation with Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits.
Top 5 Women’s Health Articles of 2024
Take a look at this year’s top articles — one showcasing enhanced weight loss through Semaglutide use in post-menopausal women on hormonal therapy.